73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Cancer-predisposition variants associated with adverse outcomes in rhabdomyosarcoma

Cancer-predisposition variants associated with adverse outcomes in rhabdomyosarcoma

by Molly Chiu,Baylor College of MedicineKaplan-Meier Survival Outcomes of Cancer-Predisposition Variant (CPV) Status on Rhabdomyosarcoma (RMS). Credit:JAMA Network Open(2024). DOI: 1

Cancer-predisposition variants associated with adverse outcomes in rhabdomyosarcoma

by Molly Chiu,Baylor College of MedicineKaplan-Meier Survival Outcomes of Cancer-Predisposition Variant (CPV) Status on Rhabdomyosarcoma (RMS). Credit:JAMA Network Open(2024). DOI: 1
A new way to predict complications after larynx cancer surgery

A new way to predict complications after larynx cancer surgery

by Nicole Fawcett,University of MichiganRebecca Hoesli, M.D., and Matthew Spector, M.D., evaluate an image from the study Credit: University of Michigan Rogel Cancer CenterA technique that illum

A new way to predict complications after larynx cancer surgery

by Nicole Fawcett,University of MichiganRebecca Hoesli, M.D., and Matthew Spector, M.D., evaluate an image from the study Credit: University of Michigan Rogel Cancer CenterA technique that illum
Survey finds one in three patients needed more information on cancer treatment side effects

Survey finds one in three patients needed more information on cancer treatment side effects

by American Society for Radiation OncologyIn a nationwide survey of US adults treated for cancer, 1 in 3 patients said they experienced side effects from cancer treatment that they wish they'

Survey finds one in three patients needed more information on cancer treatment side effects

by American Society for Radiation OncologyIn a nationwide survey of US adults treated for cancer, 1 in 3 patients said they experienced side effects from cancer treatment that they wish they'
Oncology therapy at the end-of-life: Have we missed the mark?

Oncology therapy at the end-of-life: Have we missed the mark?

by Yale Cancer CenterCredit:JAMA Oncology(2022). DOI: 10.1001/jamaoncol.2022.4666Continued treatment for patients with cancer near end-of-life delays conversations about goals of care and

Oncology therapy at the end-of-life: Have we missed the mark?

by Yale Cancer CenterCredit:JAMA Oncology(2022). DOI: 10.1001/jamaoncol.2022.4666Continued treatment for patients with cancer near end-of-life delays conversations about goals of care and
ACS sets goal to cut cancer mortality 40 percent by 2035

ACS sets goal to cut cancer mortality 40 percent by 2035

(HealthDay)—The American Cancer Society (ACS) has set a goal of a 40 percent reduction in overall cancer mortality by 2035, according to a study published online May 8 inCA: A Cancer Journal for

ACS sets goal to cut cancer mortality 40 percent by 2035

(HealthDay)—The American Cancer Society (ACS) has set a goal of a 40 percent reduction in overall cancer mortality by 2035, according to a study published online May 8 inCA: A Cancer Journal for
Fluidity predicts aggressiveness of cancerous tumors, study

Fluidity predicts aggressiveness of cancerous tumors, study

by Leipzig UniversityTumour-associated microscopic effects such as the liquification or increased fluidity of cancer cells have an effect on the tumour’s macroscopic mechanical properties. These

Fluidity predicts aggressiveness of cancerous tumors, study

by Leipzig UniversityTumour-associated microscopic effects such as the liquification or increased fluidity of cancer cells have an effect on the tumour’s macroscopic mechanical properties. These
Neoadjuvant endocrine therapy may elicit differential responses in Black and white women with breast cancer

Neoadjuvant endocrine therapy may elicit differential responses in Black and white women with breast cancer

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainBlack women treated with neoadjuvant endocrine therapy for breast cancer were more likely to benefit than white women

Neoadjuvant endocrine therapy may elicit differential responses in Black and white women with breast cancer

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainBlack women treated with neoadjuvant endocrine therapy for breast cancer were more likely to benefit than white women
CAR T cell therapy may eliminate tumor cells missed by surgery

CAR T cell therapy may eliminate tumor cells missed by surgery

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainCAR T cell therapy, an approach which reprograms patients' own immune cells to attack their blood canc

CAR T cell therapy may eliminate tumor cells missed by surgery

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainCAR T cell therapy, an approach which reprograms patients' own immune cells to attack their blood canc
Exercise improves cardiorespiratory fitness during and after chemotherapy

Exercise improves cardiorespiratory fitness during and after chemotherapy

by American College of CardiologyCredit: Pixabay/CC0 Public DomainDuring chemotherapy, physical exercise intervention is safe, improves long-term cardiorespiratory fitness, and alleviates some of

Exercise improves cardiorespiratory fitness during and after chemotherapy

by American College of CardiologyCredit: Pixabay/CC0 Public DomainDuring chemotherapy, physical exercise intervention is safe, improves long-term cardiorespiratory fitness, and alleviates some of
First line immunotherapy combination fails to improve overall survival in lung cancer

First line immunotherapy combination fails to improve overall survival in lung cancer

by European Society for Medical OncologyStudy author Dr Naiyer Rizvi, director of thoracic oncology and immunotherapeutics, Columbia University Medical Center, New York, US. Credit: © European So

First line immunotherapy combination fails to improve overall survival in lung cancer

by European Society for Medical OncologyStudy author Dr Naiyer Rizvi, director of thoracic oncology and immunotherapeutics, Columbia University Medical Center, New York, US. Credit: © European So
Study reveals aggressive prostate cancer linked to ancestral heritage

Study reveals aggressive prostate cancer linked to ancestral heritage

byUniversity of SydneyCredit:Nature(2022). DOI: 10.1038/s41586-022-05154-6Two pioneering studies published simultaneously today inNatureandGenome Medicine, have ide

Study reveals aggressive prostate cancer linked to ancestral heritage

byUniversity of SydneyCredit:Nature(2022). DOI: 10.1038/s41586-022-05154-6Two pioneering studies published simultaneously today inNatureandGenome Medicine, have ide
Effectiveness of a new bladder cancer treatment demonstrated

Effectiveness of a new bladder cancer treatment demonstrated

by IMIM (Hospital del Mar Medical Research Institute)Credit: IMIMResearchers from the Molecular Cancer group at the Hospital del Mar Medical Research Institute (IMIM) and doctors from Hospital del Mar

Effectiveness of a new bladder cancer treatment demonstrated

by IMIM (Hospital del Mar Medical Research Institute)Credit: IMIMResearchers from the Molecular Cancer group at the Hospital del Mar Medical Research Institute (IMIM) and doctors from Hospital del Mar